BKBurcu Kok Kendirlioglu

Burcu Kok Kendirlioglu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Burcu Kok Kendirlioglu has a total of 48 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Cyclopurine DNA lesions and repair in individuals with bipolar disorder and their unaffected siblings

    by Hidayet Ece Arat Çelik, Gamze Tuna, İzel Cemre Akşahin, Selda Yılmaz, İbrahim Fettahoğlu, Aysan Eslami Abriz, Ceren Gör, Esma Çörekli, Burcu Kök Kendirlioğlu, Nazlı Ecem Dal Bekar, et al.

  • SuPAR levels are increased in sera of euthymic patients with bipolar disorder and correlate with executive functions and memory

    by Burcu Kök Kendirlioğlu, Esma Çörekli Kaymakçı, Tuğba Hacıosmanoğlu, Hidayet Ece Arat Çelik, Nurcan Orhan

  • Combination of ketamine and electroconvulsive therapy in treatment resistant depression

    by Burcu Kök Kendirlioğlu, Melike Özmen, Sudesu Uluçay, Tolga Bayrak, Elif Sude Erturan, Özge Salkım, Ayşe Ece Büyüksandalyacı Tunç, Hidayet Ece Arat Çelik, Suat Küçükgöncü


  • May Resolvin D1 Represent Axonal Damage as Well as Chronic Inflammation in Bipolar Disorder?

    by Burcu Kök Kendirlioğlu, Özge Yüksel Öksüz, Tevfik Kalelioğlu, Şule Sözen, Pelin Ünalan Özperçin, Refik Cihnioğlu, Nesrin Karamustafalıoğlu

    Bipolar disorder (BD) is a chronic disorder associated with significant psychiatric morbidity and disability. Recent research has linked inflammatory processes to the pathology of BD. Resolvin D1 (RvD1), an anti-inflammatory molecule derived from eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), has been shown to inhibit apoptosis and neuroinflammation, and promote neurogenesis. This study aims to determine changes in serum RvD1 levels between acute episode and euthymic periods in patients with BD and their association with inflammatory and metabolic syndrome (MetS) parameters. This prospective clinical study was conducted with patients diagnosed with BD-I according to SCID-5. Patients whose serum RvD1 levels were assessed during manic and depressive episodes in the previous study were invited to return to the study after at least 8 weeks, when they had reached the euthymic period. Blood samples for RvD1, C-reactive protein (CRP), and hemogram tests were collected during both acute episodes and remission periods. The study included 32 patients in manic episodes, 27 in depressive episodes, and 41 healthy controls, with no significant age difference among the groups. RvD1 levels decreased significantly from manic episodes to complete remission period (p=0.017, z=-2.391) during follow-up. The decrease from depression to remission was not statistically significant. Serum RvD1 levels in patients with depressive episodes in remission remained high in the control group (p=0.581, z=-0.553). During the follow-up period, white blood cell (p=0.009, z=-2.606) and neutrophil (p=0.007, z=-2.693) in mania period and CRP values in depression period (p=0.004, z=-2.880) were found to have decreased statistically. The study indicates that serum RvD1 levels are elevated during manic and depressive episodes in BD patients compared to healthy controls and decrease significantly during the remission period in patients with manic episode. We propose the potential utility of RvD1 as a diagnostic marker for identifying manic and depressive states. We can assume that there is an inflammatory process in BD in which RvD1 also plays a role. Further research is needed to explore the therapeutic potential of targeting RvD1 pathways in BD treatment.


  • Effects of Sexual Myths and Intimate Partner Violence on Women’s Sexual Self-Schemas

    by Burcu Kok Kendirlioglu, Suat Kucukgoncu

    Sexual self-schemas (SSSs) are cognitive generalizations about one’s sexual aspects. The aim of this study was to explore the possible effects of intimate partner violence (IPV) and the sexual myths about sexual behavior or roles on women’s sexual self-schemas. The research had a cross-sectional and observational design. Fifty women from a psychiatry outpatient clinic between the ages of 18–50 were given the Sexual Self-Schema Scale, sexual myths questionnaire, Beck Depression Inventory, Beck Anxiety Inventory, Golombok-Rust Inventory of Sexual Satisfaction, and Domestic Violence Against Women Scale. A significant relationship was found between the duration of marriage (years) and “Direct/Outspoken” schema (p = .020, r = 0.29). This schema was also correlated with emotional (p = .037, r = − 0.29), total violence score (p = .028, r = − 0.27), and sexual myth score (p = .033, r = 0.26). After the regression analysis, it was observed that the effect of emotional violence and sexual myth score on the “Direct/Outspoken” schema remained significant. Correcting sexual myths through sexual education can make women’s SSSs into positive way. In addition, interventions can be made to increase SSSs positively in women exposed to IPV. It is recommended that clinicians take a holistic approach by questioning the sexual functions and schemas of women in addition to IPV in women who experience it and have depression or anxiety disorders. As a policy implication, education about women’s rights and sexuality should also be given. Adequate psychological support should be provided to reduce the impact of IPV on SSS.


  • Lymphocyte-related ratios, systemic immune-inflammatory and systemic inflammatory response index in alcohol use disorder

    by Burcu Kok Kendirlioglu, Hidayet Ece Arat Celik, Ayse Ece Buyuksandalyaci Tunc, Melike Ozmen, Esma Corekli Kaymakcı, Sevin Demir, Suat Kuçukgoncu

    Addictive disorders are associated with systemic and central nervous system inflammation, which may be important for the onset and development of these diseases. Although lymphocyte-related parameters have recently been studied in alcohol use disorder (AUD), systemic immune-inflammation index (SII) and systemic inflammatory response index (SIRI) haven't. Lymphocyte-related ratios, SII and SIRI levels were evaluated between AUD and healthy controls (HC) in this study. It was a retrospective and cross-sectional study. This study included 72 patients with AUD and 184 individuals in the HC group. Lymphocyte related ratios such as neutrophil to lymphocyte ratio (NLR), monocyte to lymphocyte ratio (MLR) and platelet to lymphocyte ratio (PLR), SII and SIRI values were compared. Compared to HC group, NLR (p < 0.001), MLR (p < 0.001), and SIRI (p < 0.001) levels were significantly higher in AUD group. There was also a significant relationship between NLR and AST/ALT ratio in the AUD group (p = 0.022). The results of this study support that AUD is a chronic inflammatory psychiatric disorder. In addition, it may be useful to evaluate these markers in relation to liver enzymes in patients with AUD, as alcohol consumption causes liver damage. These markers may also be used in future studies to assess treatment response and disease severity.


  • Open Access

    Childhood trauma and neurocognitive functions in individuals with bipolar disorder and unaffected siblings of individuals with bipolar disorder

    by Hidayet Ece Arat-Çelik, Gamze Tuna, Burcu Kök-Kendirlioğlu, Esma Çörekli, Neşe Yorguner, Zeynep Teke, Deniz Ceylan


  • Paraphilias, Sociodemographic and Forensic Profiles of Men Convicted of Sexual Offenses in Turkey

    by Burcu Kok Kendirlioglu, Derya Ipekcioglu, Nedim Havle, Mehmet Cem Ilnem

    This study investigated the psychiatric, paraphilic, and forensic profiles of men who were convicted of sexual offenses. It also examined childhood trauma exposure in the group with potential paraphilia. The study was performed in the closed prison located in the Istanbul Silivri Penal Institutions Campus. The interview data of 100 men convicted of sexual offenses were obtained from the psychiatric interview notes based on the DSM-5 criteria, the results of the 28-item Childhood Trauma Questionnaire administered to the participants with paraphilia, and the forensic profiles from examination files. It was found that 39% of individuals were drug users and 36% were alcohol users. Considering the crime scenes, 42% of men convicted of sexual offenses committed the offense in their own house. Pedophilia was the most common among men with paraphilia (59%). The victim age was significantly lower ( p < .001), and the male victim ratio was higher ( p < .05) in the group with paraphilia than in the group without paraphilia. Sexual offenses against children aged 10 years and below and against males may be suggestive of paraphilia and an increased risk of recidivism.


  • Could Weight Loss During Clozapine Therapy be an Indicator of Poor Response?: A Case Report

    by Burcu Kok Kendirlioglu, Aytul Gursu Hariri

    Even though effectiveness of clozapine on treatment resistant schizophrenia has been repeatedly demonstrated, it is also associated with many adverse effects including weight gain. Curiously, significant weight loss may occur in some patients. In this case report we discussed whether the observed weight loss could be a negative prognostic factor. The 56 year-old male patient, followed up with the diagnosis of schizophrenia for 20 years, had persistent positive and negative symptoms despite concurrent use of different antiypsychotics. He was diagnosed with treatment-resistant schizophrenia and started on clozapine with dose titration to 500 mg/day over 3 months. He was observed to have lost 17.6% of his initial body weight after 7 months of therapy. The Positive and Negative Syndrome Scale (PANSS) score of the patient did not change significantly. There are a few case reports in the literature on weight loss during clozapine therapy. Some proposed that the weight loss could be a sign of weak response to treatment which is based on the observation that the clinical response might be poor when there is a weight loss and no change in blood triglyceride levels is observed with the treatment. There is a need for more case-control and preclinical studies to explain the mechanisms underlying weight loss and weak response to clozapine therapy in schizophrenia.